leadership
confidence high
sentiment neutral
materiality 0.30
Sensei Biotherapeutics appoints two new directors, expanding board to five
Sensei Biotherapeutics, Inc.
- Board increased from 3 to 5 members; Christopher W. Gerry (President & GC) and Phillip B. Donenberg appointed Feb 13, 2026.
- Gerry already serves as President and General Counsel of the company.
- Donenberg brings CFO and audit committee experience from Taysha, Tectonic, Jaguar Gene Therapy, and AveXis.
- Donenberg will receive non-employee director compensation per 2025 proxy statement.
- Each appointee entered standard indemnification agreement with the company.